Filing Flows › Comparisons › NPCE vs PDEX
NeuroPace vs Pro DEX: NPCE and PDEX compared
NeuroPace is the larger company: $22.8M of revenue in its latest quarter (Q2 2026) against $20.6M for Pro DEX (Q1 FY27). NeuroPace is growing faster (+17% against +11% a year earlier). Pro DEX is more profitable, with an operating margin of 17.1% against -22.5%.
Where the money goes: NPCE and PDEX
NeuroPace (NPCE) · Q2 2026
NeuroPace, Q2 2026: revenue $22.8M (+17% year over year), operating margin -22.5%, net loss $6.2M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
Pro DEX (PDEX) · Q1 FY27
Pro DEX, Q1 FY27: revenue $20.6M (+11% year over year), operating margin 17.1%, net earnings $3.0M, operating cash flow $6.5M. The chart follows the revenue to costs, profit and cash.
| NeuroPace (NPCE) | Pro DEX (PDEX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $22.8M | $20.6M |
| Revenue growth, Y/Y | +17% | +11% |
| Gross margin | — | 33.4% |
| Operating margin | -22.5% | 17.1% |
| Net earnings | −$6.2M | $3.0M |
| Net margin | -27.2% | 14.8% |
| Operating cash flow | −$3.9M | $6.5M |
| Free cash flow | — | $6.1M |
Questions
Which is bigger, NeuroPace or Pro DEX?
NeuroPace is the larger company: $22.8M of revenue in its latest quarter (Q2 2026) against $20.6M for Pro DEX (Q1 FY27).
Is NeuroPace or Pro DEX growing faster?
NeuroPace is growing faster (+17% against +11% a year earlier).
Which is more profitable, NeuroPace or Pro DEX?
Pro DEX is more profitable, with an operating margin of 17.1% against -22.5%.
More: NeuroPace earnings · how NeuroPace makes money · Pro DEX earnings · how Pro DEX makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.